MEDICINE & HEALTH

Filip Peters, CEO of Acorai

Changing the Game in Heart Failure Diagnosis: Acorai's Innovative Tech Saving Lives

The current standard for assessing the severity of heart failure often involves invasive procedures, which only a mere 8% of patients have access to due to limitations in healthcare infrastructure and resources. This gap in care delivery has left clinicians reliant on less precise methods, leading to inaccuracies in diagnosis and treatment. Enter Acorai, a pioneering medical technology company with a mission to expand access to accurate heart failure diagnosis.
41 42 43 44 45 46 47 48 49 50  

Recommended Stories

Real Time Analytics